{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T09:20:44Z","timestamp":1759483244251},"reference-count":31,"publisher":"Japanese Society of Hypertension","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2006]]},"DOI":"10.1291\/hypres.29.123","type":"journal-article","created":{"date-parts":[[2006,6,6]],"date-time":"2006-06-06T05:54:38Z","timestamp":1149573278000},"page":"123-128","source":"Crossref","is-referenced-by-count":23,"title":["Long-Term Vardenafil Therapy Improves Hemodynamics in Patients with Pulmonary Hypertension"],"prefix":"10.1291","volume":"29","author":[{"given":"Kazunori","family":"AIZAWA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"HANAOKA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"KASAI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaoru","family":"KOGASHI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Setsuo","family":"KUMAZAKI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"KOYAMA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"TSUTSUI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshikazu","family":"YAZAKI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noboru","family":"WATANABE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"KINOSHITA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uichi","family":"IKEDA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"119","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Archer S, Rich S: Primary pulmonary hypertension: a vascular biology and translational research &ldquo;work in progress.&rdquo; <i>Circulation<\/i> 2000; <b>102<\/b>: 2781-2791.","DOI":"10.1161\/01.CIR.102.22.2781"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Newman JH: Treatment of primary pulmonary hypertension&mdash;the next generation. <i>N Engl J Med<\/i> 2002; <b>346<\/b>: 933-934.","DOI":"10.1056\/NEJM200203213461212"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)11024-5"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Beavo JA: Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. <i>Physiol Rev<\/i> 1995; <b>75<\/b>: 725-748.","DOI":"10.1152\/physrev.1995.75.4.725"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Ahn HS, Foster M, Cable M, Pitts BJ, Sybertz EJ: Ca\/CaM-stimulated and cGMP-specific phosphodiesterases in vascular and non-vascular tissues. <i>Adv Exp Med Biol<\/i> 1991; <b>308<\/b>: 191-197.","DOI":"10.1007\/978-1-4684-6015-5_15"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Lepore JJ, Maroo A, Pereira NL, <i>et al<\/i>: Effect of sildenafil on the acute pulmonary vasodilator response to inhaled nitric oxide in adults with pulmonary hypertension. <i>Am J Cardiol<\/i> 2002; <b>90<\/b>: 677-680.","DOI":"10.1016\/S0002-9149(02)02586-9"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000016641.12984.DC"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Cheitlin MD, Hutter AM Jr, Brindis RG, <i>et al<\/i>: Use of sildenafil (viagra) in patients with cardiovascular disease. <i>Circulation<\/i> 1999; <b>99<\/b>: 168-177.","DOI":"10.1161\/01.CIR.99.1.168"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Zhao L, Mason NA, Morrell NW, <i>et al<\/i>: Sildenafil inhibits hypoxia-induced pulmonary hypertension. <i>Circulation<\/i> 2001; <b>104<\/b>: 424-428.","DOI":"10.1161\/hc2901.093117"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Shekerdemian LS, Ravn HB, Penny DJ: Intravenous sildenafil lowes pulmonary vascular resistance in a model of neonatal pulmonary hypertension. <i>Am J Respir Crit Care Med<\/i> 2002; <b>165<\/b>: 1098-1102.","DOI":"10.1164\/ajrccm.165.8.2107097"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Kataoka M, Satoh T, Manabe T, <i>et al<\/i>: Oral sildenafil improves primary pulmonary hypertension refractory to epoprostenol. <i>Circ J<\/i> 2005; <b>69<\/b>: 461-465.","DOI":"10.1253\/circj.69.461"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Abrams D, Schulze-Neick I, Magee AG: Sildenafil as a selective pulmonary vasodilator in childhood primary pulmonary hypertension. <i>Heart<\/i> 2000; <b>84<\/b>: E4.","DOI":"10.1136\/heart.84.2.e4"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000099502.17776.C2"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1067\/mcp.2002.123554"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Corbin JD, Beasley A, Blount MA, Francis SH: Vardenafil: structural basis for higher potency over sildenafil in inhibiting cGMP-specific phoshodiesterase-5 (PDE5). <i>Neurochem Int<\/i> 2004; <b>45<\/b>: 859-863.","DOI":"10.1016\/j.neuint.2004.03.016"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Ghofrani HA, Voswinckel R, Reichenberger F, <i>et al<\/i>: Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension. <i>J Am Coll Cardiol<\/i> 2004; <b>44<\/b>: 1488-1496.","DOI":"10.1016\/j.accreview.2004.12.025"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijir.3900726"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Ikeda D, Tsujino I, Ohira H, <i>et al<\/i>: Addition of oral sildenafil to beraprost is a safe and effective therapeutic option for patients with pulmonary hypertension. <i>J Cardiovas Pharmacol<\/i> 2005; <b>45<\/b>: 286-289.","DOI":"10.1097\/01.fjc.0000155386.49103.ce"},{"key":"19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200011023431814"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Wharton J, Strange JW, Moller GM, <i>et al<\/i>: Anti-proliferative effects of phosphodiesterase type 5 inhibition in human pulmonary artery cells. <i>Am J Respir Care Med<\/i> 2005; <b>172<\/b>: 105-113.","DOI":"10.1164\/rccm.200411-1587OC"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Heinrike W, Angelika G, Jochem K, <i>et al<\/i>: Effect of inhaled iloprost plus oral sildenafil in patients with primary pulmonary hypertension. <i>Circulation<\/i> 2001; <b>104<\/b>: 1218-1222.","DOI":"10.1161\/hc3601.096826"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.27.101"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Foresta C, Lana A, Cabrelle A, <i>et al<\/i>: PDE-5 inhibitor, vardenafil, increases circulating progenitor cells in humans. <i>Int J Impot Res<\/i> 2005; <b>17<\/b>: 377-380.","DOI":"10.1038\/sj.ijir.3901325"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Nagaya N, Nishikimi T, Uematsu M, <i>et al<\/i>: Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension. <i>Circulation<\/i> 2000; <b>102<\/b>: 865-870.","DOI":"10.1161\/01.CIR.102.8.865"},{"key":"25","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.26.669"},{"key":"26","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.25.887"},{"key":"27","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.27.625"},{"key":"28","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.26.971"},{"key":"29","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.26.847"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Eric R, Evangelos DM, Wayne T, <i>et al<\/i>: Sildenafil use in patients with the Eisenmenger syndrome. <i>Circulation<\/i> 2004; <b>109<\/b>: 197.","DOI":"10.1161\/01.CIR.0000127113.72093.45"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Marius MH, Roman M, Joern T, <i>et al<\/i>: Determination of cardiac output by the Fick method, thermodilution, and acetylene rebreathing in pulmonary hypertension. <i>Am J Respir Crit Care Med<\/i> 1999; <b>160<\/b>: 535-541.","DOI":"10.1164\/ajrccm.160.2.9811062"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,4,19]],"date-time":"2019-04-19T05:09:26Z","timestamp":1555650566000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.nature.com\/doifinder\/10.1291\/hypres.29.123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1291\/hypres.29.123","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006]]}}}